Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan; Department of Internal Medicine, Taiwan.
Department of Internal Medicine, Taiwan.
Clin Microbiol Infect. 2015 Mar;21(3):250.e1-7. doi: 10.1016/j.cmi.2014.08.025. Epub 2014 Oct 29.
Very few studies have focused on the outcome and management of patients with a single sputum isolate of nontuberculous mycobacterium (NTM) on initial examination. Patients with a single isolate of Mycobacterium avium complex (MAC), M. chelonae-abscessus, M. kansasii, or M. fortuitum from at least three sputum samples collected within 1 month were retrospectively identified. Those with follow-up sputum samples within 1 year were included in the analysis. Among the 202 patients included, M. fortuitum (n = 71, 35.1%) and MAC (n = 70, 34.7%) were the most common NTM species isolated, followed by M. chelonae-abscessus (n = 40, 19.8%) and M. kansasii (n = 21, 10.4%). The mean clinical follow-up period was 26.2 months. Forty-four patients (21.8%) had subsequent positive cultures of the same NTM species, while eight (4.0%) had bronchiectasis and developed NTM lung disease (NTM-LD). Neither patients without bronchiectasis nor those with M. fortuitum subsequently developed NTM lung disease. Among bronchiectatic patients with NTM other than M. fortuitum, age ≤65 years (p 0.006, OR 32.13), malignancy (p 0.048, OR 14.35), and initial radiographic score >2 (p 0.027, OR 20.06) were associated with subsequent NTM-LD. In all of the NTM patients, bronchiectasis (p <0.001, OR 5.46) and age ≤65 years (p 0.002, OR 3.29) were significantly associated with subsequent positive NTM culture. In patients with a single isolation of NTM from respiratory specimens, the presence of bronchiectasis and younger age indicates higher risk of subsequent culture-positivity and NTM-LD. Single isolation of M. fortuitum is of little clinical significance. Other patients with NTM, younger age, and more severe radiographic pulmonary lesion also warrant further attention.
很少有研究关注初始检查时仅从单一痰培养物中分离出非结核分枝杆菌(NTM)的患者的结局和处理。回顾性鉴定了至少 3 个月内收集的 3 次痰样本中分离出单一鸟分枝杆菌复合体(MAC)、脓肿分枝杆菌/龟分枝杆菌、堪萨斯分枝杆菌或偶然分枝杆菌的患者。对 1 年内有随访痰样本的患者进行了分析。在 202 名患者中,最常见的 NTM 物种是脓肿分枝杆菌(n = 71,35.1%)和 MAC(n = 70,34.7%),其次是脓肿分枝杆菌/龟分枝杆菌(n = 40,19.8%)和堪萨斯分枝杆菌(n = 21,10.4%)。平均临床随访时间为 26.2 个月。44 名患者(21.8%)随后培养出相同的 NTM 物种阳性,而 8 名患者(4.0%)发生支气管扩张并出现 NTM 肺部疾病(NTM-LD)。无支气管扩张的患者和未发生脓肿分枝杆菌感染的患者均未随后发生 NTM 肺部疾病。在非脓肿分枝杆菌的支气管扩张患者中,年龄≤65 岁(p 0.006,OR 32.13)、恶性肿瘤(p 0.048,OR 14.35)和初始放射评分>2(p 0.027,OR 20.06)与随后的 NTM-LD 相关。在所有 NTM 患者中,支气管扩张(p<0.001,OR 5.46)和年龄≤65 岁(p<0.001,OR 3.29)与随后的 NTM 培养阳性显著相关。在呼吸道标本中分离出单一 NTM 的患者中,支气管扩张和年龄较小提示随后培养阳性和 NTM-LD 的风险更高。单一分离出的脓肿分枝杆菌意义不大。其他 NTM 患者、年龄较小和更严重的肺部放射病变也需要进一步关注。